IDegLira for type 2 diabetes: a systematic review and meta-analysis
Y Liu, X Li, Y Zheng, X Wang, X Wang - Endocrine, 2024 - Springer
Objectives IDegLira is a novel fixed-ratio soluble combination of insulin degludec and the
glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide approved for type 2 diabetes …
glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide approved for type 2 diabetes …
Recent advances in the treatment of type 2 diabetes mellitus using new drug therapies
K Chong, JKJ Chang… - The Kaohsiung Journal of …, 2024 - Wiley Online Library
Several recent advances provide multiple health benefits to individuals with type 2 diabetes
mellitus (T2DM). Pharmacological therapy is governed by person‐centered factors …
mellitus (T2DM). Pharmacological therapy is governed by person‐centered factors …
Physical performance strongly predicts all-cause mortality risk in a real-world population of older diabetic patients: machine learning approach for mortality risk …
Background Prognostic risk stratification in older adults with type 2 diabetes (T2D) is
important for guiding decisions concerning advance care planning. Materials and methods A …
important for guiding decisions concerning advance care planning. Materials and methods A …
Novel Activity of Oral Hypoglycemic Agents Linked with Decreased Formation of Tryptophan Metabolite, Kynurenic Acid
K Bednarz, K Kozieł, EM Urbańska - Life, 2024 - mdpi.com
Kynurenic acid is a tryptophan (Trp) metabolite formed along the kynurenine (KYN) pathway
in the brain and in peripheral tissues. The disturbed formation of kynurenic acid, which …
in the brain and in peripheral tissues. The disturbed formation of kynurenic acid, which …
[HTML][HTML] Prevention of preeclampsia
F Brownfoot, DL Rolnik - Best Practice & Research Clinical Obstetrics & …, 2024 - Elsevier
Preeclampsia is a relatively common pregnancy complication and constitutes a major cause
of morbidity and mortality for mothers and children worldwide. It disproportionally affects low …
of morbidity and mortality for mothers and children worldwide. It disproportionally affects low …
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 …
EA Christofides, O Puente, P Norwood… - Diabetes, Obesity …, 2024 - Wiley Online Library
Aim To evaluate the equivalence of immunogenicity, safety and efficacy of Gan & Lee (GL)
Glargine (Basalin®; Gan & Lee Pharmaceutical) with that of the reference product (Lantus®) …
Glargine (Basalin®; Gan & Lee Pharmaceutical) with that of the reference product (Lantus®) …
[HTML][HTML] Risk stratification in people with diabetes for fasting during Ramadan: consensus from Arabic Association for the Study of Diabetes and Metabolism
I Shaltout, AM Abdelwahab, A El Meligi… - Current Diabetes …, 2024 - ncbi.nlm.nih.gov
Background Current international guidelines recommend a pre-Ramadan risk assessment
for people with diabetes (PwDM) who plan on fasting during the Holy month. However, a …
for people with diabetes (PwDM) who plan on fasting during the Holy month. However, a …
Influence of Solute Carrier Family 22 Member 1 (SLC22A1) Gene Polymorphism on Metformin Pharmacokinetics and HbA1c Levels: A Systematic Review
AD Pradana, E Kristin… - Current Diabetes …, 2024 - ingentaconnect.com
Background: Solute Carrier Family 22 Member 1 (SLC22A1, also known as OCT1) protein
has a vital role in the metabolism of metformin, a first-line anti-diabetes medication. Genetic …
has a vital role in the metabolism of metformin, a first-line anti-diabetes medication. Genetic …
Efficacy and safety of basal insulins in people with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials
Aim The comparative effectiveness of basal insulins has been examined in several studies.
However, current treatment algorithms provide a list of options with no clear differentiation …
However, current treatment algorithms provide a list of options with no clear differentiation …
In Vitro and Molecular Docking Evaluation of the Anticholinesterase and Antidiabetic Effects of Compounds from Terminalia macroptera Guill. & Perr. (Combretaceae)
RT Feunaing, AN Tamfu, AJY Gbaweng, S Kucukaydin… - Molecules, 2024 - mdpi.com
Alzheimer's disease (AD) and diabetes are non-communicable diseases with global
impacts. Inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are …
impacts. Inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are …